These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28431490)

  • 1. New challenges in therapeutic vaccines against HIV infection.
    Leal L; Lucero C; Gatell JM; Gallart T; Plana M; García F
    Expert Rev Vaccines; 2017 Jun; 16(6):587-600. PubMed ID: 28431490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell based vaccines for HIV infection: the way ahead.
    García F; Plana M; Climent N; León A; Gatell JM; Gallart T
    Hum Vaccin Immunother; 2013 Nov; 9(11):2445-52. PubMed ID: 23912672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dendritic cells in HIV-immunotherapy.
    Van Gulck E; Van Tendeloo VF; Berneman ZN; Vanham G
    Curr HIV Res; 2010 Jun; 8(4):310-22. PubMed ID: 20353393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis.
    Coelho AV; de Moura RR; Kamada AJ; da Silva RC; Guimarães RL; Brandão LA; de Alencar LC; Crovella S
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Immune Interventions for an HIV-1 Cure.
    Perreau M; Banga R; Pantaleo G
    Trends Mol Med; 2017 Oct; 23(10):945-961. PubMed ID: 28890135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine and immunotherapeutic interventions.
    Pantaleo G; Lévy Y
    Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a cure for HIV--Seeking effective therapeutic vaccine strategies.
    Autran B
    Eur J Immunol; 2015 Dec; 45(12):3215-21. PubMed ID: 26542079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change.
    Pantaleo G; Levy Y
    Curr Opin HIV AIDS; 2016 Nov; 11(6):576-584. PubMed ID: 27607591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining drug and immune therapy: a potential solution to drug resistance and challenges of HIV vaccines?
    Endsley AN; Salama NN; Ho RJ
    Curr HIV Res; 2008 Sep; 6(5):401-10. PubMed ID: 18855650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.
    Vacas-Córdoba E; Climent N; De La Mata FJ; Plana M; Gómez R; Pion M; García F; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2014 Dec; 9(17):2683-702. PubMed ID: 25529571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding HIV infection for the design of a therapeutic vaccine. Part II: Vaccination strategies for HIV.
    de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
    Ann Pharm Fr; 2015 May; 73(3):169-79. PubMed ID: 25528627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
    Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
    Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
    Vanham G; Van Gulck E
    Retrovirology; 2012 Sep; 9():72. PubMed ID: 22958464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic vaccines against HIV infection.
    García F; León A; Gatell JM; Plana M; Gallart T
    Hum Vaccin Immunother; 2012 May; 8(5):569-81. PubMed ID: 22634436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic vaccination against HIV: current progress and future possibilities.
    Puls RL; Emery S
    Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking globally relevant vaccine strategies to human immunodeficiency virus type-1.
    Gray CM; Puren AJ
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):235-41. PubMed ID: 11059639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions.
    Graziani GM; Angel JB
    J Int AIDS Soc; 2015; 18(1):20497. PubMed ID: 26561337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.